Testing effectiveness (Phase 2)UnknownNCT02828878
What this trial is testing
Prevention of Acute Graft Versus Host Disease in Patients Undergoing Allogeneic ApoGraft Stem Cell Transplantation
Who this might be right for
Hematological Malignancies
Cellect Biotechnology 12